Company description

LIVN, also known as LivaNova PLC, is a global medical technology company that specializes in developing and selling innovative solutions for the treatment of cardiac and neurological disorders. The company was formed through the 2015 merger of Sorin Group, an Italian cardiovascular company, and Cyberonics, a US-based neurological device manufacturer. With its headquarters in London, LIVN has a strong presence in more than 100 countries worldwide, with over 4,000 employees dedicated to improving patients' lives. The company's product portfolio includes cutting-edge technologies such as heart-lung machines, pacemakers, and neuromodulation devices, which are used in the treatment of conditions such as heart failure, epilepsy, and depression. LIVN is committed to continuous innovation, investing heavily in research and development to further expand its product range and enhance patient outcomes. The company also has a strong focus on sustainability, striving to minimize its environmental impact while providing high-quality, life-saving devices. With a strong financial performance and a dedicated team of experts, LIVN is poised for continued growth as it continues to make a positive impact on the healthcare industry.